Mary T Am Ende

Title: Innovations by Mary T Am Ende

Introduction

Mary T Am Ende is a notable inventor based in Waterford, CT (US). She has made significant contributions to the field of pharmaceuticals, holding a total of three patents. Her work focuses on developing innovative solutions to address health-related issues, particularly in the realm of addiction and hormone regulation.

Latest Patents

One of her latest patents is directed to controlled-release (CR) oral pharmaceutical dosage forms of 5,8,14-triazatetracyclo[10.3.1.00]-hexadeca-2(11),3,5,7,9-pentaene, and pharmaceutically acceptable salts thereof. This invention aims to reduce nicotine addiction and aid in the cessation or lessening of tobacco use while minimizing nausea as an adverse effect. Another significant patent involves sustained release formulations for growth hormone secretagogues. This invention relates to formulations that allow for part of the dose to be administered using an immediate release formulation, while the remainder is delivered through a sustained release formulation.

Career Highlights

Mary T Am Ende is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role at Pfizer allows her to contribute to the development of groundbreaking pharmaceutical products that can improve patient outcomes.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including William John Curatolo and Scott Max Herbig. These collaborations have likely enhanced her research and development efforts, leading to innovative solutions in her field.

Conclusion

Mary T Am Ende's contributions to pharmaceutical innovations demonstrate her commitment to improving health outcomes through her inventions. Her work continues to impact the industry positively, showcasing the importance of innovation in addressing critical health challenges.